Article Details
Retrieved on: 2021-04-28 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here